{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T08:04:19Z","timestamp":1649145859699},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1007\/s00115-013-3943-0","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T16:33:27Z","timestamp":1386693207000},"page":"1525-1536","source":"Crossref","is-referenced-by-count":0,"title":["Neuritis nervi optici"],"prefix":"10.1007","volume":"84","author":[{"given":"H.","family":"Steffen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,12,6]]},"reference":[{"key":"3943_CR1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/archopht.1992.01080150029020","volume":"110","author":"Beck","year":"1992","unstructured":"Beck RW (1992) The optic neuritis treatment trial. Implications for clinical practice. Optic Neuritis Study Group. Arch Ophthalmol 110(3):331\u2013332","journal-title":"Arch Ophthalmol"},{"key":"3943_CR2","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1001\/archopht.126.7.994","volume":"126","author":"Beck","year":"2008","unstructured":"Beck RW, Gal RL (2008) Treatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trial. Arch Ophthalmol 126(7):994\u2013995","journal-title":"Arch Ophthalmol"},{"key":"3943_CR3","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archopht.126.7.996","volume":"126","author":"Volpe","year":"2008","unstructured":"Volpe NJ (2008) The optic neuritis treatment trial: a definitive answer and profound impact with unexpected results. Arch Ophthalmol 126(7):996\u2013999","journal-title":"Arch Ophthalmol"},{"key":"3943_CR4","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1212\/01.WNL.0000152873.82631.B3","volume":"64","author":"Roed","year":"2005","unstructured":"Roed HG et al (2005) A double-blind, randomized trial of iv immunoglobulin treatment in acute optic neuritis. Neurology 64(5):804\u2013810","journal-title":"Neurology"},{"key":"3943_CR5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1468-1331.2008.02258.x","volume":"15","author":"Tselis","year":"2008","unstructured":"Tselis A et al (2008) Treatment of corticosteroid refractory optic neuritis in multiple sclerosis patients with intravenous immunoglobulin. Eur J Neurol 15(11):1163\u20131167","journal-title":"Eur J Neurol"},{"key":"3943_CR6","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/S0140-6736(00)04725-5","volume":"357","author":"Comi","year":"2001","unstructured":"Comi G et al (2001) Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study. Lancet 357(9268):1576\u20131582","journal-title":"Lancet"},{"key":"3943_CR7","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S0140-6736(09)61259-9","volume":"374","author":"Comi","year":"2009","unstructured":"Comi G et al (2009) Effect of glatiramer acetate on conversion to clinically definite multiple sclerosis in patients with clinically isolated syndrome (PreCISe study): a randomised, double-blind, placebo-controlled trial. Lancet 374(9700):1503\u20131511","journal-title":"Lancet"},{"key":"3943_CR8","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S1474-4422(09)70237-6","volume":"8","author":"Kappos","year":"2009","unstructured":"Kappos L et al (2009) Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurol 8(11):987\u2013997","journal-title":"Lancet Neurol"},{"key":"3943_CR9","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1056\/NEJM200009283431301","volume":"343","author":"Jacobs","year":"2000","unstructured":"Jacobs LD et al (2000) Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. N Engl J Med 343(13):898\u2013904","journal-title":"N Engl J Med"},{"key":"3943_CR10","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1212\/01.wnl.0000200778.65597.ae","volume":"66","author":"Kinkel","year":"2006","unstructured":"Kinkel RP et al (2006) IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event. Neurology 66(5):678\u2013684","journal-title":"Neurology"},{"key":"3943_CR11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S1474-4422(07)70216-8","volume":"6","author":"Wingerchuk","year":"2007","unstructured":"Wingerchuk DM et al (2007) The spectrum of neuromyelitis optica. Lancet Neurol 6(9):805\u2013815","journal-title":"Lancet Neurol"},{"key":"3943_CR12","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1212\/WNL.0b013e3181af78b8","volume":"73","author":"Ratchford","year":"2009","unstructured":"Ratchford JN et al (2009) Optical coherence tomography helps differentiate neuromyelitis optica and MS optic neuropathies. Neurology 73(4):302\u2013308","journal-title":"Neurology"},{"key":"3943_CR13","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/ana.20851","volume":"59","author":"Costello","year":"2006","unstructured":"Costello F et al (2006) Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol 59(6):963\u2013969","journal-title":"Ann Neurol"},{"key":"3943_CR14","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1001\/archopht.121.7.944","volume":"121","author":"Beck","year":"2003","unstructured":"Beck RW et al (2003) High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. Arch Ophthalmol 121(7):944\u2013949","journal-title":"Arch Ophthalmol"},{"key":"3943_CR15","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00415-010-5467-x","volume":"257","author":"Henderson","year":"2010","unstructured":"Henderson AP et al (2010) A preliminary longitudinal study of the retinal nerve fiber layer in progressive multiple sclerosis. J Neurol 257(7):1083\u20131091","journal-title":"J Neurol"},{"key":"3943_CR16","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S1474-4422(10)70168-X","volume":"9","author":"Petzold","year":"2010","unstructured":"Petzold A et al (2010) Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol 9(9):921\u2013932","journal-title":"Lancet Neurol"},{"key":"3943_CR17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1212\/WNL.0b013e3181aaea32","volume":"73","author":"Naismith","year":"2009","unstructured":"Naismith RT et al (2009) Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis. Neurology 73(1):46\u201352","journal-title":"Neurology"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-013-3943-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-013-3943-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-013-3943-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T05:14:56Z","timestamp":1558588496000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-013-3943-0"}},"subtitle":["Aus augen\u00e4rztlicher Sicht"],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":17,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3943"],"URL":"https:\/\/doi.org\/10.1007\/s00115-013-3943-0","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}